These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30169797)

  • 1. Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers.
    Matthews AK; Steffen AD; Kuhns LM; Ruiz RA; Ross NA; Burke LA; Li CC; King AC
    Nicotine Tob Res; 2019 Oct; 21(11):1506-1516. PubMed ID: 30169797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a comparative effectiveness evaluation of a culturally tailored versus standard community-based smoking cessation treatment program for LGBT smokers.
    Matthews AK; McConnell EA; Li CC; Vargas MC; King A
    BMC Psychol; 2014; 2(1):12. PubMed ID: 25566383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a community-based smoking cessation treatment program for LGBT smokers.
    Matthews AK; Li CC; Kuhns LM; Tasker TB; Cesario JA
    J Environ Public Health; 2013; 2013():984508. PubMed ID: 23840237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Smoking Cessation Outcomes for Sexual Minority Versus Nonminority Smokers in a Large Randomized Controlled Trial of Two Web-Based Interventions.
    Heffner JL; Mull KE; Watson NL; McClure JB; Bricker JB
    Nicotine Tob Res; 2020 Aug; 22(9):1596-1604. PubMed ID: 31290550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking Cessation Programs for Lesbian, Gay, Bisexual, Transgender, and Intersex People: A Content-Based Systematic Review.
    Berger I; Mooney-Somers J
    Nicotine Tob Res; 2017 Nov; 19(12):1408-1417. PubMed ID: 27613909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Qualitative Study of the Barriers to and Facilitators of Smoking Cessation Among Lesbian, Gay, Bisexual, and Transgender Smokers Who Are Interested in Quitting.
    Matthews AK; Cesario J; Ruiz R; Ross N; King A
    LGBT Health; 2017 Feb; 4(1):24-33. PubMed ID: 28068208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers.
    Taylor AH; Thompson TP; Greaves CJ; Taylor RS; Green C; Warren FC; Kandiyali R; Aveyard P; Ayres R; Byng R; Campbell JL; Ussher MH; Michie S; West R
    Health Technol Assess; 2014 Jan; 18(4):1-324. PubMed ID: 24433837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Avatar-Led Intervention Promotes Smoking Cessation in Young Adults: A Pilot Randomized Clinical Trial.
    Karekla M; Savvides SN; Gloster A
    Ann Behav Med; 2020 Oct; 54(10):747-760. PubMed ID: 32383736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.
    Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
    Addict Behav; 2011; 36(1-2):144-7. PubMed ID: 20869812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Treatment Acceptability and 12-Month Cessation Rates in Response to Web-Based Smoking Interventions Among Smokers Who Do and Do Not Screen Positive for Affective Disorders: Secondary Analysis.
    Watson NL; Heffner JL; Mull KE; McClure JB; Bricker JB
    J Med Internet Res; 2019 Jun; 21(6):e13500. PubMed ID: 31219052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation outcomes among sexual and gender minority and nonminority smokers in extended smoking treatments.
    Grady ES; Humfleet GL; Delucchi KL; Reus VI; Muñoz RF; Hall SM
    Nicotine Tob Res; 2014 Sep; 16(9):1207-15. PubMed ID: 24727483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and Quit Rates of the Tobacco Status Project: A Facebook Smoking Cessation Intervention for Young Adults.
    Ramo DE; Thrul J; Chavez K; Delucchi KL; Prochaska JJ
    J Med Internet Res; 2015 Dec; 17(12):e291. PubMed ID: 26721211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
    Taylor AH; Thompson TP; Streeter A; Chynoweth J; Snowsill T; Ingram W; Ussher M; Aveyard P; Murray RL; Harris T; Green C; Horrell J; Callaghan L; Greaves CJ; Price L; Cartwright L; Wilks J; Campbell S; Preece D; Creanor S
    Health Technol Assess; 2023 Mar; 27(4):1-277. PubMed ID: 37022933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
    Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
    Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incentives for smoking cessation.
    Cahill K; Hartmann-Boyce J; Perera R
    Cochrane Database Syst Rev; 2015 May; (5):CD004307. PubMed ID: 25983287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of a Nicotine Replacement Therapy Sample at Outdoor Smoking Hotspots for Promoting Quit Attempts: A Pilot Randomized Controlled Trial.
    Cheung YTD; Cheung Li WH; Wang MP; Lam TH
    Nicotine Tob Res; 2020 Aug; 22(9):1468-1475. PubMed ID: 31404466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.